Aurobindo Pharma
History
| Year | Detail |
|---|---|
| 1986 | Established Aurobindo Pharma Limited (APL). |
| 1988 - 1989 | Commenced manufacturing semi synthetic penicillins. |
| 1992 - 1993 | Started another unit was established for the manufacture of CMIC Chloride. |
| 1994 - 1995 | Merged with Chaitanya Organics Pvt. Ltd. |
| 1997 - 1998 | Formed an alliance with Glaxo (India) the Indian. |
| 1999 - 2000 | Sri Chakra Remedies Ltd was amalgamated with Aurobindo Pharma Limited. |
| 2001 - 2002 | Acquired 79% stake in Ranit Pharma Co. |
| 2003 - 2004 | Joint Venture between APL and Shanxi Tongling Pharmaceuticals launched. |
| 2004 - 2005 | Received US FDA clearance for AIDS drugs. |
| 2005 - 2006 | Aurobindo made a strategic entry into the premium markets of U.S. and Europe. |
| 2007 - 2008 | Acquired intellectual property and marketing authorizations with TAD Italy. |
| 2014 - 2016 | Acquired certain commercial operations in Western Europe from Actavis Plc. |
| 2017 - 2018 | Acquired Generis in Portugal. |
| 2019 - 2020 | Started setting up an oral solid manufacturing facility at Taizhou for China. |
| 2021 | Acquired 9 OTC brands. |
BCC Research Beacon 